Collegium Pharmaceutical, Inc. (COLL)
35.62
-1.00
(-2.72%)
USD |
NASDAQ |
Mar 11, 16:00
35.62
0.00 (0.00%)
After-Hours: 16:46
Collegium Pharmaceutical EPS Diluted (Quarterly) : 0.4604 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1994 |
| Johnson & Johnson | 2.098 |
| Rigel Pharmaceuticals, Inc. | 13.54 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Axsome Therapeutics, Inc. | -0.5641 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 16.96M |
| Revenue (Quarterly) | 205.45M |
| Total Expenses (Quarterly) | 188.49M |
| Enterprise Value | 1.692B |
| Gross Profit Margin (Quarterly) | 62.49% |
| Profit Margin (Quarterly) | 8.26% |
| Earnings Yield | 4.82% |
| Operating Earnings Yield | 13.65% |
| Normalized Earnings Yield | 5.843 |